N-salicyloyl tryptamine derivatives as potential therapeutic agents for doxorubicin-induced hepatotoxicity via PI3K/AKT/HO-1 signaling pathway.

Zhao Y, Zeng J, Pang G, Wu Y, Wang S, Lei Z, Hao X, Chen Y, Hu C, Zeng X, Huang X, Zhong X, Wang Z, Peng X

DOI: 10.3389/fphar.2026.1929788
Published: 2026
Container: Frontiers in pharmacology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1929788,
  title = {N-salicyloyl tryptamine derivatives as potential therapeutic agents for doxorubicin-induced hepatotoxicity via PI3K/AKT/HO-1 signaling pathway.},
  author = {Zhao Y and Zeng J and Pang G and Wu Y and Wang S and Lei Z and Hao X and Chen Y and Hu C and Zeng X and Huang X and Zhong X and Wang Z and Peng X},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1929788},
  url = {https://doi.org/10.3389/fphar.2026.1929788}
}

RIS

TY  - JOUR
TI  - N-salicyloyl tryptamine derivatives as potential therapeutic agents for doxorubicin-induced hepatotoxicity via PI3K/AKT/HO-1 signaling pathway.
AU  - Zhao Y
AU  - Zeng J
AU  - Pang G
AU  - Wu Y
AU  - Wang S
AU  - Lei Z
AU  - Hao X
AU  - Chen Y
AU  - Hu C
AU  - Zeng X
AU  - Huang X
AU  - Zhong X
AU  - Wang Z
AU  - Peng X
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1929788
UR  - https://doi.org/10.3389/fphar.2026.1929788
ER  -

APA

Y, Z., J, Z., G, P., Y, W., S, W., Z, L., X, H., Y, C., C, H., X, Z., X, H., X, Z., Z, W., & X, P. (2026). N-salicyloyl tryptamine derivatives as potential therapeutic agents for doxorubicin-induced hepatotoxicity via PI3K/AKT/HO-1 signaling pathway.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1929788

Source records

pubmed · retrieved 2026-11-10T11:04:39.581Z